Skip to content

Application of Neutrophil Gelatinase-Associated Lipocalin (NGAL) Combined with D-dimer in Early Diagnosis of Sepsis-Associated Acute Kidney Injury (SA-AKI)

Application of Neutrophil Gelatinase-Associated Lipocalin (NGAL) Combined with D-dimer in Early Diagnosis of Sepsis-Associated Acute Kidney Injury (SA-AKI)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118425
Enrollment
Unknown
Registered
2026-02-05
Start date
2025-07-08
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis-Associated Acute Kidney Injury

Interventions

Gold Standard:The 2012 KDIGO guidelines for the diagnosis of AKI (meeting any of the following criteria): an increase in serum creatinine (Scr) of =0.3 mg/dL (26.5 µmol/L) within 48 hours
an increase in serum creatinine to =1.5 times baseline, with the above changes known or presumed to have occurred within 7 days
urine output <0.5 mL/kg/h for more than 6 hours.
Index test:Neutrophil Gelatinase-Associated Lipocalin and D-dimer

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old; 2.Sepsis is diagnosed in accordance with the Sepsis 3.0 diagnostic criteria: there is confirmed or suspected infection, and the Sequential Organ Failure Assessment (SOFA) score is >= 2 points. 3. The definition of AKI includes an increase in SCr of >=0.3 mg/dl (>=26.5 µmol/l) within 48 hours, an increase in SCr to >=1.5 times the baseline within the past 7 days, or urine output <0.5 ml/kg/h for 6 hours.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of chronic renal insufficiency; 2.Patients who have developed AKI at the time of admission. 3.Patients who have undergone renal surgery, have renal vascular abnormalities, or have received a kidney transplant; 4.Patients with increased intra-abdominal pressure (intra-abdominal pressure =12 mmHg). 5.Patients with urinary tract infections. 6.Pregnant or lactating women. 7.Patients who refuse to participate in this study.

Design outcomes

Primary

MeasureTime frame
Biomarkers for the Assessment of Coagulation Dysfunction in Sepsis Patients.;Urine output < 0.5 mL/kg/h for =6 hours is a criterion for AKI;Designed for the early diagnosis of AKI in sepsis patients;Designed for the early diagnosis of AKI;Sensitivity;Specificity;

Countries

China

Contacts

Public ContactLiangbin Hu

The Affiliated Hospital of Southwest Medical University

1304860246@qq.com+86 181 8030 0106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026